Menlo Park, California -- North America venture capital funding history for Medical Devices & Instruments rebounded in Q2 2015 to nearly a 7 1/2 year high.
The chart indicates continued strength in venture capital interest in medical devices, with a Q2 investment aggregate in excess of $1 billion.
This is no doubt due in part to the continued strong IPO environment for medical devices.
In the second half of 2015, 2 of 11 technology IPOs were medical device companies who floated their offering either within or above their expected pricing range.
ConforMIS (NASDAQ: CFMS) raised $135 million in its initial offering and Penumbra (NYSE: PEN) raised $120 million in gross proceeds for its offering.
M&A activity in 2015 also continues to be busy, with 6 published acquisitions of Medical Device firms.
One of the most recent acquisitions was Allergan's takeover of Aliso Viejo-based AqueSys. AqueSys was developing a device for the treatment of primary open angle glaucoma and was acquired for $300 million in upfront cash plus milestone payments.
As long as the environment is robust for M&A and IPO exit options, Medical Device firms will enjoy the continued interest of venture capital investors.